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Abstract
Aims: To design and synthesize a library of structurally related, small
molecules related to homologues of compounds produced by the plant
Petiveria alliacea and determine their ability to interfere with AI-2 cell–cell
communication and biofilm formation by oral bacteria. Many human diseases
are associated with persistent bacterial biofilms. Oral biofilms (dental plaque)
are problematic as they are often associated with tooth decay, periodontal
disease and systemic disorders such as heart disease and diabetes.
Methods and Results: Using a microplate-based approach, a bio-inspired
small molecule library was screened for anti-biofilm activity against the oral
species Streptococcus mutans UA159, Streptococcus sanguis 10556 and
Actinomyces oris MG1. To complement the static screen, a flow-based BioFlux
microfluidic system screen was also performed under conditions representative
of the human oral cavity. Several compounds were found to display biofilm
inhibitory activity in all three of the oral bacteria tested. These compounds
were also shown to inhibit bioluminescence by Vibrio harveyi and were thus
inferred to be quorum sensing (QS) inhibitors.
Conclusion: Due to the structural similarity of these compounds to each
other, and to key molecules in AI-2 biosynthetic pathways, we propose that
these molecules potentially reduce biofilm formation via antagonism of QS or
QS-related pathways.
Significance and Impact of the Study: This study highlights the potential for a
non-antimicrobial-based strategy, focused on AI-2 cell–cell signalling, to control
the development of dental plaque. Considering that many bacterial species use
AI-2 cell–cell signalling, as well as the increased concern of the use of
antimicrobials in healthcare products, such an anti-biofilm approach could also
be used to control biofilms in environments beyond the human oral cavity.
Introduction
Oral biofilms, the most visually conspicuous being dental
plaque, are surface-attached bacterial communities
encased within an intricate network of extracellular poly-
meric substances produced by the constituent bacteria
(Kolenbrander et al. 2006). The biofilm mode of growth
confers distinct advantages over planktonic lifestyles. In
the case of the oral cavity, bacterial cell encapsulation
within biofilms first and foremost reduces the likelihood
of their translocation to inhospitable environments such
as the stomach (Kolenbrander and London 1993; Marsh
et al. 2011). Bacteria within oral biofilms also profit from
the local exchange of nutrient by-products from juxta-
posed biofilm species (Marsh 2005). Most importantly,
the biofilm presents a formidable barricade that not only
Journal of Applied Microbiology 117, 1472--1486 © 2014 The Society for Applied Microbiology1472
Journal of Applied Microbiology ISSN 1364-5072
protects biofilm bacteria from host immune defences and
adverse changes in the environment, but also presents an
impenetrable barrier to antibiotics to which the bacteria
might otherwise be susceptible (Costerton 1999; Stewart
and Costerton 2001; Gilbert et al. 2002; Stewart 2002;
Lewis 2007). Collectively, these factors make oral biofilms
recalcitrant to physical and chemical treatment strategies
(Hall-Stoodley et al. 2004; Marsh 2005).
From a human health perspective, biofilms present in
the oral cavity of individuals impose significant potential
for not only the development of oral infections, leading
to dental caries and periodontal disease, but may also be
linked to cardiovascular disease, obesity, complications
during pregnancy, diabetes and respiratory diseases
(Scannapieco 1999; Scannapieco et al. 2003; Costerton
and Keller 2007; Paju and Scannapieco 2007; Selwitz
et al. 2007; Zeigler et al. 2012). Oral biofilms can also
serve as a nucleus for the horizontal transfer of antimi-
crobial resistance genes between bacteria (Roberts and
Mullany 2010).
Multiple pathways regulate formation of biofilms, but
one key target that has been demonstrated to inhibit or
retard biofilm development is quorum sensing (QS) (Kol-
enbrander et al. 2002, 2010; Hojo et al. 2009; Shao and
Demuth 2010). QS is a population-dependent communi-
cation system that allows micro-organisms to coordinate
group behaviour in a manner that enables them to act as
a multi-cellular single entity. QS uses the accumulation
of molecules often referred to as autoinducers to regulate
gene expression. Many of these are virulence-related
(Parsek and Greenberg 2000; Winans and Bassler 2002;
March and Bentley 2004; Vendeville et al. 2005). Autoin-
ducer-2 (AI-2) is an umbrella term commonly used to
describe a family of inter-convertible molecules in equi-
librium formed by spontaneous cyclization of the unsta-
ble molecule 4,5-dihydroxy-2,3-pentanedione (DPD)
(Semmelhack et al. 2005). AI-2 has been proposed to be
an inter-species signal, and numerous species have been
shown to engage in AI-2-mediated communication (Fed-
erle and Bassler 2003; Xavier and Bassler 2003). AI-2 is a
by-product of the activated methyl cycle and is generated
by the cleavage of S-ribosylhomocysteine into homocyste-
ine by the enzyme LuxS (Schauder et al. 2001). LuxS/AI-
2-based QS has been demonstrated to regulate biofilm
formation in an assortment of oral bacteria. Streptococcus
mutans luxS mutants were shown to be deficient in bio-
film formation and displayed downregulation in many
biofilm-related genes (Merritt et al. 2003; Sztajer et al.
2008). Biofilm formation by an Strep. mutans luxS
mutant has also been shown to be restored by comple-
mentation when grown in the presence of certain Strepto-
coccus, Porphyromonas and Aggregatibacter species
(Yoshida et al. 2005). Furthermore, Streptococcus oralis 34
and Actinomyces naeslundii T14V were shown to have a
mutualistically dependent biofilm-forming relationship
that was dependent upon AI-2 in a concentration-depen-
dent manner (Rickard et al. 2006). Several other studies
link LuxS/AI-2-based signalling with oral biofilm forma-
tion and the expression of other virulence factors which
ultimately induce acid tolerance, oxidative stress and bac-
teriocin production states (Blehert et al. 2003; Stroeher
et al. 2003; Wen and Burne 2004; Merritt et al. 2005;
Ahmed et al. 2009; Shemesh et al. 2010). Thus, interfer-
ing with AI-2-based cell–cell communication may inter-
rupt biofilm formation, which may serve as a viable
strategy for improving oral and systemic health. In partic-
ular, manipulating the expression of virulence factors
while minimizing cytotoxic effects in bacteria may be an
attractive approach to disease treatment, as it lowers the
pressure of natural selection and therefore may reduce
the likelihood of the development of microbial resistance
(Rasmussen and Givskov 2006b; Brackman et al. 2009;
Njoroge and Sperandio 2009; Kalia 2013).
Plants are perpetually exposed to microbes and prone
to bacterial invasion. Therefore, it is likely that many
flora have developed mechanisms, such as QS inhibition,
to defend against harmful pathogens (Rasmussen and
Givskov 2006a). Thus, plant metabolites may serve as a
significant untapped resource for compounds that miti-
gate the incursion of infection through inhibition of QS
in pathogenic bacteria (Koh et al. 2013). In this regard, a
number of studies have shown that plant-derived organo-
sulphur natural products such as iberin and ajoene, iso-
lated from horseradish and garlic, respectively, inhibit QS
and virulence in Pseudomonas aeruginosa (Jakobsen et al.
2012a,b). Another interesting class of small molecule nat-
ural products is the halogenated furanones initially iso-
lated from the marine algae Delisea pulchra, which were
demonstrated to inhibit acyl-homoserine lactone (AHL)-
mediated communication in several marine bacteria
(Givskov et al. 1996). Synthetic derivatives of these com-
pounds have since been shown to inhibit AHL-mediated
QS and virulence in Ps. aeruginosa, AI-2-mediated QS in
Vibrio harveyi and biofilm formation by several orally
associated bacteria (Hentzer et al. 2002; Wu et al. 2004;
L€onn-Stensrud et al. 2007; He et al. 2012). Previously, we
reported that derivatives of metabolites from the flower-
ing plant Petiveria alliacea, namely substituted cysteine
sulphoxides and diphenyl disulphides, can reduce
Ps. aeruginosa biofilm formation and QS, as well as bacte-
rial infection in a Drosophila model (Cady et al. 2012).
The aim of this study was to expand upon the library
of S-substituted cysteine sulphoxide-based derivatives and
to explore the biofilm inhibitory activity of these com-
pounds against bacteria that are relevant to the human oral
microbiome, namely Strep. mutans UA159, Streptococcus
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sanguis 10556 and Actinomyces oris MG1. Streptococcus
mutans is most notorious as an etiological agent of dental
caries (Ajdic et al. 2002). Streptococcus sanguis is consid-
ered a pioneer colonizer and is known as one of the earli-
est bacteria to recolonize the tooth surface, postremoval
(Ge et al. 2008). Actinomyces oris is also an early colo-
nizer that attaches to the tooth surface, serving as a foun-
dation for subsequent attachment of other species
(Kolenbrander et al. 2006; Dige et al. 2009). To investi-
gate potential interference of inter-species communica-
tion, compounds were also tested in a luminescence-
based AI-2 QS reporter, V. harveyi BB170. Of the 46
compounds screened, six compounds inhibited biofilm
formation in all three indigenous oral bacteria, while five
of these six also inhibited luminescence by the AI-2 QS
reporter strain V. harveyi BB170.
Materials and methods
Strains, standard culture conditions and reagents
The oral strains Strep. mutans UA159, Strep. sanguis
10556 and Act. oris MG1 were used in this study
(Strep. mutans UA159 was kindly donated by Prof. Tom
Wen, Microbiology, Immunology and Parasitology, Loui-
siana State University, and Act. oris MG1 was kindly
donated by Dr. Paul Kolenbrander, NIDCR, NIH, Beth-
esda). All were grown on brain–heart infusion agar and
brain–heart infusion broth (BHI; Difco/Becton Dickin-
son, Franklin Lakes, NJ) at 37°C under 5% CO2 atmo-
sphere. All reagents, unless otherwise noted, were
purchased from Sigma-Aldrich (St. Louis, MO).
Tested compounds
S-(2-Aminoethyl)-L-cysteine hydrochloride (1), taurine
(2), L-cysteic acid (3), glycinamide hydrochloride (4),
()-carnitine hydrochloride (5), S-carboxylmethyl-L-cys-
teine (6), diphenyl disulphide (12), dibenzyl sulphide
(13), dibenzyl disulphide (14), sulfolane (18), S-methyl-
L-cysteine (28), L-carnosine (29), djenkolic acid (35),
S-ethyl-L-cysteine (36), S-(4-tolyl)-L-cysteine (37),
S-(2-thienyl)-L-cysteine (38), S-(2-thiazoyl)-L-cysteine
(39), S-propyl-L-cysteine (40) and S-phenyl-L-cysteine
(41) were purchased from Sigma-Aldrich and were used
without further purification. Cysteine sulphoxides 7, 8, 9,
10, 11, 21, 22, 23, 24, 25, 32, 34, 42, 43 and 44 are
known compounds and were synthesized by hydrogen
peroxide-mediated oxidation of the corresponding cyste-
ines and fully characterized as we have described previ-
ously (Kubec et al. 2002; Musah et al. 2009; He et al.
2011; Cady et al. 2012). S-Substituted 19, 20, 26, 27, 30
and 45 were synthesized by treatment of cysteine with the
corresponding alkyl bromide (obtained from Sigma-
Aldrich) in the presence of aqueous NaOH and fully
characterized as described previously (Musah et al. 2009;
He et al. 2011; Cady et al. 2012). Disulphides 15 and 16
were synthesized by sodium periodate-mediated oxidation
of the corresponding sulphides and fully characterized as
described previously (Cady et al. 2012). Compound 33
was synthesized as described by Johnson and Ambler
(1914). Compounds 46, 17 and 31 were prepared by
H2O2-promoted oxidation of the corresponding S-substi-
tuted-L-cysteines as described by us previously (Cady
et al. 2012). Stock solutions of compounds
(100 mmol l1) were dissolved in DMSO (7, 12–17, 37),
300 mmol l1 NaOH (1, 6, 8–11, 19–28, 32, 34–36, 38–
46) or H2O (2–5, 18, 29–33) depending on solubility.
Static biofilm inhibition assay
A microplate-based assay, modified from work by
Gutierrez and colleagues and O’Toole and colleagues,
was used to screen compounds for biofilm inhibition
(O’Toole et al. 1999; Gutierrez et al. 2009). The growth
media for biofilm formation was 25% (v/v) BHI supple-
mented with 2% (w/v) sucrose (BHIS). For the initial
screen, stock solutions were used to bring the final com-
pound concentration in the growth media to
1 mmol l1. Briefly, Strep. mutans UA159 BHI broth cul-
tures were grown for 18 h at 37°C and 5% CO2 without
agitation. The 18-h culture was diluted 1 : 100 in BHIS
with compound. Volume equivalents of DMSO,
300 mmol l1 NaOH and dH2O were used as positive
controls to compounds diluted in each accordingly. An
aliquot (100 ll) of each cell/compound mixture was
added to three separate wells of a glass-bottom 96-well
plate (Thermo Fisher Scientific, Rochester, NY). Total
biofilm growth time was 48 h, at 37°C, 5% CO2. After
the first 24 h, spent media/planktonic solution was
removed and replaced with fresh media and compound.
To quantify biofilm formation after 48 h, planktonic
solution was removed and biofilms were washed twice
with 100 ll dH2O. Biofilms were stained with 50 ll of
SYTO 9 (Invitrogen, Carlsbad, CA) (5 lmol l1) for
15 min at room temperature. The fluorescent dye was
then removed, and the biofilm was washed twice with
100 ll of dH2O. The fluorescence intensity (485 nm
excitation/520 nm emission) was determined from 12
spots in each well. Confocal laser scanning microscopy
was performed using a Leica TCS SP5 II microscope
using a 209 oil-immersion lens with 488 nm excitation
and 510–540 nm emission detection range. LEICA APPLICA-
TION SUITE v2.2.2 software was used for image acquisition.
Subsequent manipulation was performed using IMARIS
(Bitplane, Zurich, Switzerland) software.
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Autoinducer-2 assay
Quorum sensing inhibition studies were performed using
a modified protocol described by Vilchez et al. (2007).
The strains used for this assay were V. harveyi BB170
(Kmr; luxN::Tn5; AI-1 positive; AI-2 positive) and
V. harveyi BB152 (Kmr; luxLM::Tn5; AI-1 negative; AI-2
positive). Briefly, V. harveyi strains were grown in autoin-
ducer bioassay (AB) medium described by Greenberg
et al. (1979) with agitation (160 rev min1) at 30°C
under aerobic conditions. Cells were pelleted and then
resuspended in AB medium to an OD600 = 07. Cells
were then incubated at 30°C, 160 rev min1, for 15 h.
This was diluted 1 : 5000 in AB medium to produce the
working solution (BB170), 180 ll of which was pipetted
into each well of a 96-well plate. Twenty microlitres of
each test sample was added to each well, with three repli-
cates of each sample. The test sample consisted of com-
pound dissolved in its appropriate solvent and artificial
AI-2 (Omm Scientific, Dallas, TX) in water. The final
concentrations in each well were 1 mmol l1 and
40 lmol l1 of compound and AI-2, respectively. Positive
controls were BB170 supplemented with 40 lmol l1
AI-2 and appropriate solvent by volume, as well as BB152
for reference to wild-type-like luminescence. The negative
control was BB170 with no AI-2 and no compound, but
a volume equivalent of compound solvent added. Growth
(absorbance at 600 nm) and luminescence were moni-
tored every half an hour for 7 h at 30°C in a Tecan
M200 microplate reader. Luminescence values were first
normalized to cell growth and then used to generate a
percentage change from the positive control.
MTT assay
To determine whether the inhibition of QS and biofilm
formation was due to growth inhibition or cytotoxic
effects, the MTT assay (Roche Applied Science,
Mannheim, Germany) was used to estimate cell metabolic
activity. The colorimetric assay is based on the breakdown
of the yellow tetrazolium salt MTT to purple formazan
crystals by the reductase activity of coenzymes NADH and
NADPH. Oral bacteria were grown in 100 ll cultures on
a 96-well plate (inoculated by a 1 : 100 dilution in BHI
from an 18 h culture). Compounds effective at biofilm/
QS inhibition were added to the media before inoculation,
at a final concentration of 1 mmol l1. Cells were incu-
bated at 37°C, 5% CO2. After 24 h incubation, 10 ll of
MTT labelling reagent (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide, 5 mg ml1 in phosphate-
buffered saline) was added to each well. Four hours after
the addition of labelling reagent, 100 ll of solubilization
solution (10% SDS in 001 mol l1 HCl) was added to
each well. Plates were then incubated for another 24 h,
and the absorbance was determined at 560 nm (peak
absorbance of breakdown product) and 700 nm (reference
wavelength that was subtracted out as background). Con-
trols were biofilms grown without test compound and
media without inoculation, representing normal biofilm
growth and absence of metabolic activity, respectively.
Saliva collection for microfluidic assay
The protocol for the collection of filter-sterilized cell-free
saliva (CFS) preparation was the same as described by
Nance et al. (2013). Of particular note, stimulated saliva
was collected and stored in 30-ml stocks at 80°C. When
required, aliquots were thawed at room temperature
and were modified for compatibility with single-species
biofilm experiments as needed (described below).
BioFlux-based microfluidic flowing-saliva assay
Protocols for the BioFlux system were similar to those
used in Nance et al. (2013) with minor alterations. The
media used for experiments consisted of 25% pooled
human filter-sterilized CFS that was supplemented with
25% BHI and 2% sucrose. The experimental CFS also
contained 1 mmol l1 of compound 7, and the control
CFS contained a volume equivalent of DMSO (due to
compound 7 having initially been dissolved in DMSO). A
mid-exponential phase batch-culture inoculum of
Strep. mutans UA159, grown in BHI broth at 37°C with
5% CO2 to an OD of 04 at 600 nm, was prepared and
split into two cultures. Both cultures were pelleted via
centrifugation and washed in either the compound-con-
taining media or the control media. In the BioFlux sys-
tem, CFS was flowed through each channel and incubated
at room temperature for 20 min to create an ideal surface
for bacterial attachment. The UA159 inoculums that had
been washed in either compound-containing or control
media (and resuspended to an OD of 04 at 600 nm) were
then added to each outlet well in the amount of 100 ll.
The inoculum was flowed through each channel and
allowed to incubate at 37°C for 40 min. After incubation,
the remaining inoculum was removed from the outlet
wells and discarded. Compound-containing media or con-
trol media was added to a final volume of 1 ml to each
inlet well, depending on which respective media the inoc-
ulum in each channel was previously washed in. After
running the media through each channel for 20 h at
37°C, each channel was then stained using live/dead stain
(3 ll of both SYTO-9 and propidium iodide per 1 ml of
PBS) for 45 min. Biofilms were then imaged directly from
the BioFlux plate using a Leica SPE confocal laser scan-
ning microscope equipped with a 40 9 125 NA HCX PL
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APO infinity-corrected oil objective. Confocal images were
rendered in 3D using IMARIS (Bitplane) software. These
images were analysed for viability using IMAGEJ (Schneider
et al. 2012). They were also analysed for biovolume, aver-
age thickness and roughness coefficient using COMSTAT 2
software (Heydorn et al. 2000).
Quantitative reverse-transcription PCR
Overnight cultures (18 h) of Strep. mutans UA159 were
obtained from inoculating single colonies into 5 ml BHI
media containing either 1 mmol l1 compound 7 or
DMSO (solvent control). Total RNA was extracted using
the RNeasy kit (Qiagen, Valencia, CA) with the RNApro-
tect Bacteria Reagent (Qiagen) according to the manufac-
turer’s protocol with some modification to the cell lysis
steps. Briefly, cells were mixed with 10 ml of the RNApro-
tect reagent and harvested by centrifugation for 10 min at
5000 g. Each cell pellet was resuspended and lysed in
200 ll TE buffer (Ambion, Life Technologies, Carlsbad,
CA) containing 30 mg ml1 lysozyme (EMD Millipore,
Billerica, MA) and 30 mAU Proteinase K (Qiagen). Lysis
solutions were left shaking for 10 min at room tempera-
ture and then further lysed using a Branson Sonifier
Model 450 at 70% power, in pulse mode (10 s on, 5 s off)
for a total of 5 min sonication time. After this step, the
manufacturer’s protocol was followed strictly (Qiagen).
Total RNA samples were further treated with DNase I
(New England BioLabs, Ipswich, MA) to degrade any
residual DNA. Real-time RT-PCR was performed using
the one-step QuantiFast SYBR Green RT-PCR kit (Qia-
gen). The primers shown in Table 3 were used at 250 nM.
Cycle conditions were as follows: 30 min at 50°C; 15 min
at 95°C; 40 cycles of 15 s at 94°C, 30 s at 50°C and 30 s at
72°C. Gene expression was determined as a function of
threshold cycle (Ct) value and was normalized internally
using DNA gyrase a-subunit (SMU.1114).
Statistical analysis
Statistical significance was expressed as significant
(P < 005), highly significant (P < 001) and extremely sig-
nificant (P < 0001). Statistical analyses included t-tests,
ANOVAs and Dunnett’s multiple comparison tests, as noted.
Results
Biofilm formation by orally associated bacteria is
inhibited by several organosulphur compounds
The effects of organosulphur compounds on biofilm for-
mation by the oral strains were investigated through a sta-
tic biofilm microplate-based screening approach. The
initial concentration for the screen was 1 mmol l1, and
biofilm formation in all three organisms was affected to
varying degrees by several compounds in the library
(Fig. 1). Actinomyces oris biofilm formation was signifi-
cantly inhibited by multiple compounds, particularly 3, 7,
12, 14, 17, 37, 38 and 46 (≥30% mean reduction). Addi-
tionally, for Act. oris, several compounds appeared to
improve biofilm development, most notably compound 15
(≥30% mean increase). Similar responses were seen for
Strep. mutans, where compounds 3, 7, 9, 12, 17, 37, 38 and
46 most effectively inhibited biofilm formation and com-
pounds 15 and 18 markedly increased biofilm formation
(Fig. 1; ≥30% mean reduction/increase, respectively).
Streptococcus sanguis biofilm formation was significantly
reduced by compounds 7, 12, 13, 17, 26, 34, 35, 36, 37 and
46 (≥30% mean reduction), while it was enhanced by a
number of compounds, most notably 15, 25, 27 and 31
(Fig. 1). Compounds that inhibited biofilm formation in
all three organisms by at least 25% at 1 mmol l1 included
3, 7, 12, 17, 37 and 46. These were selected for further
dose–response assays. Compounds that increased biofilm
formation are the subject of ongoing investigations.
Biofilm formation as a function of compound
concentration revealed dose–response effects
Biofilms were grown in the presence of each of the com-
pounds that were previously shown to significantly inhi-
bit biofilm formation in all three test strains (i.e.
compounds 3, 7, 12, 17, 37 and 46), in order to deter-
mine concentration-dependent effects. An inhibitor-
response curve was fit to the observed dose–response
data, enabling calculation of the 50% inhibitory concen-
tration (IC50) for each compound (Table 1). The associ-
ated dose–response curves are shown in Fig. S1. The data
show that the IC50 values are similar in magnitude, rang-
ing from high micromolar to low millimolar concentra-
tions, with compound 7 being the most consistent in
inhibiting all three bacterial species. Our observations of
reduced biofilm formation in the presence of these com-
pounds was corroborated by the results of confocal scan-
ning laser microscopy (CLSM), which was used to
visualize the morphologies of the biofilms grown in the
presence of inhibitory compounds (Fig. 2). CLSM 3D
computational renderings showed that biofilm surface
coverage was decreased in bacteria grown in the presence
of compounds 3, 7, 12, 17, 37 and 46, with compound 7
being the most effective across all three species (Fig. 2).
In many of these experiments, microcolonies that never
developed into mature, confluent biofilms were seen. This
may suggest that these compounds do not affect initial
bacteria–surface attachment events, but instead affect the
progression of biofilm maturation.
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Figure 1 Biofilm formation by oral bacteria in the presence of AI-2 quorum sensing (QS) effectors. The data are scaled with the 100% mark rep-
resenting biofilm in the absence of added compound. Values below 100% indicate biofilm inhibition, and values above indicate increased biofilm
formation. Values are represented as percentages in comparison with the control (not shown) in which tested compounds were absent.
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Compounds that inhibit biofilm formation by multiple
species also inhibit AI-2-based QS in Vibrio harveyi
BB170
To investigate the possible connection between QS and
biofilm formation in the three strains of bacteria, and to
determine whether our panel of lead compounds inhibited
biofilm formation by curtailing AI-2-mediated QS, we uti-
lized the V. harveyi reporter strain BB170. The effects of
our lead biofilm inhibitory compounds on AI-2 QS-medi-
ated communication were investigated by exposing
V. harveyi to the compounds in the presence of exogenous
AI-2 and monitoring V. harveyi bioluminescence. Figure 3
illustrates the bioluminescence of V. harveyi BB170 grown
in the presence of compounds that inhibited biofilm for-
mation by the three oral species, that is 3, 7, 12, 17, 37
and 46, after 7 h. The data are normalized to cell growth
(as determined by OD600) and scaled so that the negative
control (no compound) is equivalent to 100%. The results
observed from screening the entire library are shown in
Fig S2. Compounds 3, 7, 12, 17 and 46 significantly
decreased the QS response in V. harveyi BB170 at
1 mmol l1 concentration. Conversely, compound 37 did
not, suggesting that it was not an AI-2 inhibitor.
Dose-dependent QSI was also investigated using
V. harveyi BB170 in the presence of compounds 3, 7, 12,
17 and 46. An inhibitor-response curve was fit to the
data, which is displayed in Fig. S3. The calculated IC50
for each compound is shown in Table 2. Compound 46
had the lowest IC50 value (0068 mmol l1), suggesting it
to be the most potent QS inhibitor in this study.
Compounds exhibit differential effects on orally
associated bacterial metabolic activity
The colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay was used to deter-
mine whether the inhibition of biofilm formation was a
result of bactericidal or bacteriostatic effects. In this assay,
metabolic activity, and more specifically, the reductive
activity of the coenzymes NADH and NADPH, can be
related to cell viability. Bacterial cultures with compound
present were inoculated into a 96-well plate and incu-
bated for 24 h. MTT reagent was added directly to cul-
tures that included both biofilm and planktonic cells (as
controls). Streptococcus mutans, Strep. sanguis and
Act. oris displayed differential metabolic activity when
grown in the presence of organosulphur biofilm inhibi-
tors (Fig. 4). The metabolic activity of the control (with-
out the addition of compound) was set at 100%, and the
other samples were scaled accordingly. Values below
100%, such as was observed for compound 3 when in the
presence of all three organisms, represent a decrease in
metabolic activity, whereas those above 100% (as
observed in the case of compound 46 in all three organ-
isms), are indicative of increased activity relative to
the control. The results indicated that, in general, Strep.
mutans had a greater tolerance for these compounds rela-
tive to the other organisms, as its metabolic activity was
increased or unaffected by four of the five biofilm/QS
inhibitors. Actinomyces oris was the most susceptible, as
Table 1 IC50 values for compounds that displayed biofilm inhibitory
activity
Compound
IC50 (mmol l
1  SE)
Streptococcus
mutans
Streptococcus
sanguis Actinomyces oris
3 137 (005) 134 (013) 088 (011)
7 096 (002) 038 (002) 061 (006)
12 068 (011) 156 (019) 161 (025)
17 144 (020) 047 (008) 028 (006)
37 099 (008) 209 (013) 092 (015)
46 093 (010) 070 (003) 098 (007)
(–)
S. mutans S. sanguis A. oris
150 um
3
7
12
17
37
46
Figure 2 Representative three-dimensional reconstructions of confo-
cal laser scanning microscopy images. The left column shows Strepto-
coccus mutans, the middle column Streptococcus sanguis, and the
right column Actinomyces oris. The top row represents the control in
which no inhibitor compounds were present, and the subsequent
rows show the inhibitor compound, which was presented in the
growth media at a concentration of 1 mmol l1.
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its metabolic activity was negatively affected by four of the
five compounds. Streptococcus sanguis showed sensitivity
similar to that of Strep. mutans, with the most notable dif-
ference being the case of compound 17, for which the met-
abolic activity of Strep. mutans was increased and
Strep. sanguis’ metabolic activity was greatly reduced (by c.
80%). In general, the biofilm inhibitory activity was greater
in magnitude than the reduction in metabolic activity and
likely reflects not only changes in growth rate but also
changes in gross cell phenotype (e.g. one that does not
support biofilm retention). Table S1 compares biofilm
formation, metabolic activity and QS effects of the com-
pounds at 1 mmol l1, with the control (no inhibitor
compound present) represented by a relative value of 1.
Compound 7 inhibits Streptococcus mutans biofilm
formation in a saliva-fed BioFlux flowcell device
The BioFlux system allows for exposure of bacteria to
environmentally germane conditions with flowing saliva.
A customized 25% saliva-based media supplemented with
BHI and sucrose was used for this experiment. Compound
7 (dissolved in DMSO) was added to this media to a final
concentration of 1 mmol l1 and was present during the
initial inoculation and overnight growth of the biofilms.
Control biofilms were grown in the same saliva-based
media containing DMSO, but not compound 7. After
20 h, visualization by CLSM showed that there was signifi-
cant inhibition of biofilm development in the compound-
containing media, as compared to the control (Fig. 5a,b).
Specifically, the development of Step. mutans biofilms in
saliva containing compound 7 resulted in a significant
decrease in biofilm biovolume and thickness (P < 005)
and a significant increase in roughness (P < 0001)
(Fig. 5c). The difference in roughness is a reflection of the
biofilm architecture changing from a heterogeneous con-
fluent covering (Fig. 5a,a’) to sparse archipelago-like
arrangements of biofilm microcolonies. Viability analyses
indicated a meagre but statistically significant decrease in
viability when biofilms were developed in the presence of
compound 7 (9624% vs 9192% viability; Fig. 5c). From a
biological perspective, this likely reflects the retention of
dead/inactive nonresponsive Strep. mutans cells in a
biofilm under flowing saliva conditions, and not direct
antimicrobial effects of compound 7.
Transcriptional analysis reveals that compound 7 affects
expression levels of biofilm-related genes in Streptococcus
mutans UA159
We investigated the effects of inhibitory compounds on
the expression of several genes associated with biofilm
development in Strep. mutans (Table 3). Streptococcus
Table 2 IC50 of AI-2-dependent luminescence by Vibrio harveyi
BB170. Compound 37 was not considered to be a quorum sensing
inhibitor, as an IC50 value could not be determined
Compound
V. harveyi BB170
IC50 (mmol l
1)
3 0727 (0050)
7 0227 (0021)
12 0525 (0016)
17 0412 (0037)
46 0068 (0008)
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Figure 4 Bacterial metabolic activity as determined by the MTT assay.
Metabolic activity was determined for each species and compared to
the MTT assay response for bacteria grown in the absence of inhibi-
tory compounds. ( ) Streptococcus mutans; ( ) Streptococcus san-
guis and (&) Actinomyces oris.
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Figure 3 Bioluminescence of Vibrio harveyi BB170 with organosul-
phur biofilm inhibitors at 1 mmol l1 concentration after 7 h of incu-
bation. Bioluminescence of the control (without compound added)
was set at 100%, and the response for the tested compounds was
normalized accordingly. ANOVA (P < 00001) was performed followed
by Dunnett’s multiple comparison test, with asterisks indicating signif-
icant (***P < 0001) reduction in bioluminescence.
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mutans UA159 cultures were grown in BHI for 18 h in
the presence of either compound 7 (treated) or DMSO
(control). RNA was isolated and used for real-time
reverse-transcription PCR (RT-PCR) to quantify tran-
script levels of several biofilm-related genes (Fig. 6). Of
these genes, gtfB (SMU_1004), which encodes for gluco-
syltransferase B (which catalyzes conversion of sucrose
into insoluble glucans), was shown to be significantly up-
regulated when Strep. mutans was exposed to compound
7. Conversely, expression of both gbpB (SMU_22) and
brpA (SMU_410), which encode for glucan-binding pro-
tein B and biofilm-regulatory protein A, respectively, was
significantly reduced in the presence of compound 7.
Expression of luxS (SMU_474) also appeared to be
downregulated although its reduced expression was not
shown to be statistically significant at P < 005.
Discussion
The data presented in this study indicate that derivatives
of natural product metabolites of the plant P. alliacea
have the ability to inhibit biofilm formation by common
oral species. In addition, our data suggest that QS inter-
ference/inhibition and the retardation of biofilm forma-
tion in oral biofilms may be interconnected and a viable
option for future control strategies. Considering the cur-
rent public health burden caused by oral diseases such as
caries and periodontal disease, as well as the unabated
development and spread of antimicrobial resistance, the
possibility of such a QS-based anti-biofilm strategy is
alluring.
The effect of biomimetic organosulphur compounds
on oral biofilm formation was investigated using a library
of 46 compounds. Six of these (3, 7, 12, 17, 37 and 46)
were identified to have ‘broad’ biofilm inhibitory activity
in the high micromolar to low millimolar concentration
range. Compounds 3, 7, 12, 17 and 46 were also shown
to have a significant inhibitory effect on AI-2-based QS,
tested with a V. harveyi BB170 QS reporter. Compounds
7, 17 and 46 are all S-substituted cysteine sulphoxides,
whereas 3 is a sulphonic acid derivative of cysteine and
an intermediate in cysteine biosynthesis, and 12 is the
20 um
(a)
(a’)
(c)
(b)
(b’)
20 um
20 um20 um
Parameter
3·30 (3·05) 0·08 (0·06)*
0·04 (0·03)*
1·96 (0·03)***
91·23 (4·92)*
5·35 (6·63)
1·09 (0·49)
96·24 (2·02)
Roughness coefficient
Viability (%)
Biovolume (µm3 µm–2)
Average thickness (µm2)
DMSO control Compound H
Figure 5 Effect of compound 7 on biofilm
development in flowing saliva, as determined
by live/dead staining after 20 h growth and
examination under a confocal scanning laser
microscopy (CLSM). (a and a’) A
representative two-dimensional and three-
dimensional image of an Streptococcus
mutans biofilm that had not been exposed to
compound 7 (i.e. 25% modified saliva
medium plus DMSO). (b and b’) A
representative two-dimensional and three-
dimensional image of an Strep. mutans
biofilm that had been developed in
compound 7 (i.e. 25% modified saliva
medium plus DMSO and compound 7).
Bars = 20 lm. (c) Computational analyses of
biofilms grown in either condition (three 3-D
renderings per condition, each from three
channels analysed). Student’s t-test:
*P < 005; ***P < 0001.
Table 3 Primers used for quantitative reverse-transcription PCR. Primers for gtfB, brpA, gbpB and luxS were reported in Wen et al. (2010). Prim-
ers for the reference gene, gyrA, were those reported in Sztajer et al. (2008)
Locus tag Gene Protein Amplicon Length Forward primer (50–30) Reverse primer (50–30)
SMU.1004 gtfB GtfB, glucan production 98 bp AGCAATGCAGCCAATCTACAAAT ACGAACTTTGCCGTTATTGTCA
SMU.410 brpA Transcriptional regulator 148 bp CGTGAGGTCATCAGCAAGGTC CGCTGTACCCCAAAAGTTTAGG
SMU.22 gbpB Glucan-binding protein 108 bp CGTGTTTCGGCTATTCGTGAAG TGCTGCTTGATTTTCTTGTTGC
SMU.474 luxS S-ribosylhomocysteinase 93 bp ACTGTTCCCCTTTTGGCTGTC AACTTGCTTTGATGACTGTGGC
SMU.1114 gyrA DNA gyrase a-subunit 163 bp TTGGTGAAGTCCTGTCACTCG TCATCATCATTGACGCCTGT
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disulphide derivative of 7. Compound 37 did not affect
AI-2 QS, which is interesting given its structural similar-
ity to compound 17 (17 is the sulphoxide derivative of
37). This observation implicates the involvement of the
sulphoxide moiety in the observed QS interference, a
heretofore unreported result.
Plots illustrating the biofilm inhibitory activities of the
five active compounds vs QS inhibition for each of the
bacteria tested were compared (Fig. 7). Most compounds
were more effective at inhibiting QS than they were at
inhibiting biofilm formation, which is demonstrated by
their location above the diagonal line in the plots
(Fig. 7). This may be attributed to the fact that AI-2-
mediated bioluminescence in V. harveyi is strictly regu-
lated by QS, whereas there are several factors including
nutrient availability and stress among other effects that
can regulate biofilm formation. The luminescence
response to AI-2 in V. harveyi BB170 is well documented,
but it is less well known how AI-2 regulates biofilm for-
mation, especially in Gram-positive bacteria. Therefore, if
these compounds are antagonizing AI-2 QS in Gram-
positive bacteria, it is not as straightforward to predict
how these bacteria will respond. Compounds 7, 12 and
46 are among the most effective in inhibiting activity
across all three organisms, as indicated by their location
within or in close proximity to the smaller box in Fig. 7
(thereby indicating ≥50% reduction in both QS and bio-
film formation). In previous work on the effects of or-
ganosulphur compounds on Ps. aeruginosa, 7 and 12
were both shown to inhibit biofilm formation and 7 was
shown to inhibit las and rhl-based QS, as well as viru-
lence in a Drosophila infection model (Cady et al. 2012).
In principle, there are several potential mechanisms by
which the active compounds described here interfere with
QS and biofilm formation. One possibility is through
competitive inhibition of AI-2-receptor binding, although
this scenario may be viewed as unlikely based on the
absence of obvious structural similarity between the
active compounds and DPD, or any of the cyclized forms
of AI-2. However, the compounds do bear resemblance
to various organosulphur small molecules that play key
roles in the activated methyl cycle, from which AI-2 is
derived. These include cysteine, S-ribosyl homocysteine
(SRH), S-adenosyl homocysteine (SAH), methionine and
S-adenosyl methionine (SAM). SRH may have the most
structural similarity to compounds 7, 17 and 46, as both
SRH and compounds 7, 17 and 46 contain sulphur
flanked by a ring containing substituent and an amino
acid moiety (Fig. 8). Gutierrez et al. showed bacterial
communication interference in Vibrio cholerae using QS
inhibitors that block the enzymatic activity that leads to
the precursors of the LuxS cleavage substrate (SRH)
(Gutierrez et al. 2009). It is possible that the compounds
presented in this study are functioning similarly and this
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Figure 6 Relative transcript levels of biofilm-related genes in Strepto-
coccus mutans in the presence of compound 7 at 1 mM. ANOVA
(P < 00001) was performed followed by Dunnett’s multiple compari-
son test, with asterisks indicating significant (*P < 005; **P < 001)
difference in the mRNA level. The control transcript level for each
gene is equal to 1. DNA gyrase a-subunit (SMU.1114) was used as a
reference gene.
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Figure 7 Comparison plots illustrating the relative reduction in bacterial phenotypes when cultured in the presence of the active organosulphur
compounds. Plots show the percentage inhibition of biofilm for each organism (y-axis) vs the percentage reduction in AI-2-mediated biolumines-
cence (quorum sensing (QS)) in Vibrio harveyi (x-axis) for compounds with at least 50% reduction in either biofilm formation or bioluminescence.
The dotted inset delineates the subset of compounds with 50% reduction in both biofilm formation and luminescence (QS inhibition).
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possibility is being investigated. However, it is also
entirely possible that QS is not affected in the oral strains
and that biofilm inhibition is a result of alternative mech-
anisms.
While we do not understand the exact mechanism(s)
by which cysteine sulphoxide derivatives affect biofilm
development and QS among diverse bacteria, there is
some structural similarity between compounds 7 and 46
in this study, and a novel signalling molecule, the inte-
grated QS stress signal (IQS), that was recently identified
by Lee et al. (2013). IQS integrates stress response (spe-
cifically to low phosphate conditions) with the las QS
system in Ps. aeruginosa. While Ps. aeruginosa does not
produce AI-2, Duan et al. (2003) have reported that AI-2
activity regulates some of the same virulence factors that
are controlled by AHL-based signalling. Compounds 7
and 46 contain aromatic ring systems analogous to that
found in IQS, but the importance of this structural fea-
ture is as yet unknown. It remains to be seen how com-
monplace IQS-like integration systems that link stress
and population sensing are in other bacteria, and
whether compounds such as 7 and 46 are interfering in
that signalling. However, such a possibility could provide
an explanation for the observed phenotypes of indige-
nous oral species in this study and those of which we
have previously reported with Ps. aeruginosa (Cady et al.
2012).
Results from our gene expression analyses are similar
to those in several other reports (Wen and Burne 2002;
Mcnab et al. 2003; Merritt et al. 2003; Senadheera et al.
2005; Yoshida et al. 2005; Duque et al. 2011). The dif-
ferential transcript levels of gtfB and gbpB that we
observed in the presence of compound 7 are similar to
those reported on Strep. mutans vicK knockout mutants
(Senadheera et al. 2005; Duque et al. 2011). VicRK is a
two-component signal transduction system, comprised of
a membrane-bound sensor kinase (VicK) and an intra-
cellular regulator protein (VicR). Phenotypes of
Strep. mutans ΔvicK include altered biofilm-forming abil-
ity when compared to the wild-type strain, as well as
drastically reduced transformation efficiency in response
to exogenous competence-stimulating peptide, a peptide-
based QS signal utilized by multiple streptococci (Senad-
heera et al. 2005). Downregulation of gbpB impaired
early stages of biofilm formation, which could be par-
tially restored by complementation with exogenous
GbpB (Duque et al. 2011). It has been suggested that
GtfB activity is increased in Strep. mutans ΔluxS (Merritt
et al. 2003). This was confirmed on the transcriptional
level during Strep. mutans log-phase growth (Yoshida
et al. 2005). The same study also showed that sucrose-
dependent biofilm formation was impaired in Strep.
mutans ΔluxS, and the same phenotype was observed in
our study. It has also been observed in Streptoccus gordo-
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Figure 8 Structures of the compounds that
were effective in this study and structurally-
similar molecules relevant for quorum sensing
(QS). Compound 37 did not inhibit
bioluminescence (QS) but did inhibit biofilm
formation. Zhao et al. showed LuxS inhibition
using S-ribosyl homocysteine (SRH) analogues
(Zhao et al. 2003). Lee et al. recently
identified QS stress signal (IQS), a signalling
molecule that integrates stress response with
QS.(Lee et al. 2013).
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nii that LuxS controls glucosyltransferase activity and
that utilization of AI-2 affects metabolism of carbohy-
drates (Mcnab et al. 2003). Additionally, it was shown
that Strep. mutans ΔbrpA did not alter initial cell attach-
ment after 6 h, but biofilm formation after 24 h was
substantially reduced (Wen and Burne 2002). This coin-
cides with our observation that our compounds were
ineffective at inhibiting Strep. mutans biofilm formation
when added after 4 h, along with a significant reduction
in brpA expression (data not shown). Taken together, all
of these observations support our working hypothesis
that the organosulphur compounds used in this study
may not directly affect initial cell attachment, but rather
affect other events related to biofilm development,
including cell–cell signalling.
In addition to the development of more potent biofilm
and QS inhibitors, global transcriptomic and proteomic
analyses of bacteria exposed to the active compounds are
being actively pursued. The effectiveness of these com-
pounds in multispecies biofilm systems, as well as against
clinical oral biofilm samples to better understand how
they may affect the normal oral flora, is also being inves-
tigated. Given the concern that the human oral cavity is
subject to selection pressures that will result in the devel-
opment of antimicrobial resistance in the residing oral
species (Roberts and Mullany 2010), strategies based
upon preventing QS are particularly enticing, especially if
shown to be effective against natural oral biofilms that
can contain hundreds of oral species.
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Additional Supporting Information may be found in the
online version of this article:
Figure S1 Dose-dependent biofilm formation of orally
associated bacteria in presence of biofilm inhibitor.
Figure S2 V. harveyi BB170 quorum sensing reporter
dose response to quorum sensing inhibitors.
Figure S3 Luminescence of V. harveyi BB170 in the
presence of entire compound library at 1 mmol l1.
Table S1 Summary of results for organosulfur com-
pounds that inhibited both AI-2 based QS and oral bac-
terial biofilm formation.
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